Marinomed's Iota-carrageenan Effective Against H1N1 - Study

by Sheela Philomena on  December 17, 2010 at 2:24 PM Drug News
RSS Email Print This Page Comment
Carrageenan, is a polymer derived from red seaweed found to be an effective antiviral in treating common cold. In present efficiency of Carrageenan against influenza virus, including H1N1 was studied. Results showed that the polymer directly binds to influenza viruses, effectively blocking the virus from attaching to cells and spreading further. In animal experiments, Carrageenan demonstrated equivalent efficacy when compared to the drug Tamiflu.
 Marinomed's Iota-carrageenan Effective Against H1N1 - Study
Marinomed's Iota-carrageenan Effective Against H1N1 - Study

"Influenza viruses still represent a substantial threat to public health on a global scale and with increasing viral resistance to Tamiflu, the need for alternatives has never been greater," commented Dr. Andreas Grassauer, CEO and co-founder of Marinomed. "This study confirms that iota-carrageenan can be used as an alternative to neuraminidase inhibitors and should be further tested for prevention and treatment of influenza A in clinical trials in humans."



Source: Eurekalert

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive